Page last updated: 2024-09-05

organophosphonates and EBV Infections

organophosphonates has been researched along with EBV Infections in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (71.43)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araki, R; Espinoza, JL; Kuzushima, K; Nakao, S; Nishimura, R; Okumura, H; Takamatsu, H; Yachie, A; Yoshida, T	1
Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S	1
Abdulkarim, B; Bourhis, J; Deutsch, E; Frascogna, V; Joab, I; Klijanienko, J; Sabri, S; Vainchenker, W; Zelenika, D	1
Pagano, JS; Raab-Traub, N; Wakisaka, N; Yoshizaki, T	1
Goh, CL; Tan, HH	1
Furukawa, M; Kondo, S; Murono, S; Nakashima, M; Shimizu, Y; Tsuji, A; Wakisaka, N; Yoshizaki, T	1
Fiedler, F; Hänel, M; Thorns, C	1

Reviews

1 review(s) available for organophosphonates and EBV Infections

Article	Year
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. American journal of clinical dermatology, 2006, Volume: 7, Issue:1 Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine	2006

Article

Year

Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.

American journal of clinical dermatology, 2006, Volume: 7, Issue:1

Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine

2006

Other Studies

6 other study(ies) available for organophosphonates and EBV Infections

Article	Year
Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2016, Volume: 80 Topics: Adolescent; Adult; Cidofovir; Cytosine; Epstein-Barr Virus Infections; Female; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Leukemia, Lymphoid; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Organophosphonates; Rituximab; Transplantation, Homologous; Treatment Outcome	2016
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5 Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpes Zoster; Herpesvirus 1, Human; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Immunocompromised Host; Meningoencephalitis; Mucositis; Myelodysplastic Syndromes; Organophosphonates; Rituximab; Viral Load	2016
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies. Oncogene, 2003, Apr-17, Volume: 22, Issue:15 Topics: Animals; Antiviral Agents; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Carcinoma; Caspase 3; Caspase 9; Caspases; Cell Division; Cidofovir; Combined Modality Therapy; Cytosine; Enzyme Activation; Epstein-Barr Virus Infections; Female; Gene Expression Regulation, Viral; Genes, bcl-2; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Remission Induction; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Virus Infections; Viral Matrix Proteins; Xenograft Model Antitumor Assays	2003
Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts. International journal of cancer, 2005, Sep-10, Volume: 116, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Interactions; Enzyme Inhibitors; Epstein-Barr Virus Infections; Humans; Hydroxamic Acids; Hydroxyurea; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Organophosphonates; Ribonucleotide Reductases; Transplantation, Heterologous; Tumor Cells, Cultured	2005
Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir. Journal of medical virology, 2008, Volume: 80, Issue:5 Topics: Adult; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Epstein-Barr Virus Infections; Humans; Magnetic Resonance Imaging; Male; Nasopharyngeal Neoplasms; Organophosphonates; Pharynx; Radiography; Ribosomal Proteins; RNA-Binding Proteins	2008
Anti-CD20 monoclonal antibody (Rituximab) and Cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement. Onkologie, 2001, Volume: 24, Issue:5 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Cidofovir; Cytosine; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphoid; Lymph Nodes; Lymphoproliferative Disorders; Meninges; Organophosphonates; Organophosphorus Compounds; Prognosis; Rituximab	2001